Recognition and prevention of nosocomial vascular device and related bloodstream infections in the intensive care unit

Critical Care Medicine

Volumn 38, Issue 8 SUPPL., 2010, Pages

  Chittick, Paul ^a   Sherertz, Robert J ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

antimicrobial impregnated catheters; bloodstream infection; prevention; bundles; catheter dressings; central venous catheter; diagnosis; lock solutions

Indexed keywords

TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTISEPSIS; BLOODSTREAM INFECTION; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; GAUZE DRESSING; HAND WASHING; HOSPITAL INFECTION; INTENSIVE CARE UNIT; MEDICAL EDUCATION; PRIORITY JOURNAL; REVIEW; THROMBOSIS PREVENTION;

EID: 77954914693     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181e6cdca     Document Type: Article

References (132)

1. Pittet D, Tarara D, Wenzel RP: Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-1601
2. Soufir L, Timsit JF, Mahe C, et al: Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: A matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999; 20:396-401
3. O'Grady NP, Alexander M, Dellinger EP, et al: Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002; 51:1-29
4. Institute for Healthcare Improvement. Available at https://www.ihi.org/ ihi. Accessed June 7, 2010
5. Saint S: Prevention of intravascular catheter-associated infections. In: Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Evidence Report/Technology Assessment, No.43. AHRG Publication No. 01-E038. Rockville, MD, Agency for Healthcare Research and Quality, 2001, pp 163-183. Available at http://www.ncbi.nlm.nih. gov/bookshelf/br.fcgi?book= hserta&part= A61334#A62173. Accessed June 7, 2010
6. Marschall J, Mermel LA, Classen D, et al: Strategies to prevent central-line associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29: S22-S30
7. Davis DA, Thomson MA, Oxman AD, et al: Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995; 274: 700-705
8. Sherertz RJ, Ely EW, Westbrook DM, et al: Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000; 132:641-648
9. Eggimann P, Harbarth S, Constantin MN, et al: Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355:1864-1868
10. Coopersmith CM, Rebmann TL, Zack JE, et al: Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med 2002; 30:59-64
11. Warren DK, Zack JE, Mayfield JL, et al: The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 2004; 126:1612-1618
12. Million Lives Campaign. Getting Started Kit: Prevent Central Line Infections How-to Guide. Cambridge, MA, Institute for Healthcare Improvement, 2008. Available at http://www.ihi.org. Accessed June 7, 2010
13. Berriel-Cass D, Adkins FW, Jones P, et al: Eliminating nosocomial infections at Ascension Health. Jt Comm J QualPatient Saf 2006; 32:612-620
14. Pronovost P, Needham D, Berenholtz S, et al: An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-2732
15. Jain M, Miller L, Belt D, et al: Decline in ICU adverse events, nosocomial infections and cost through a quality improvement initiative focusing on teamwork and culture change. Qual Saf Health Care 2006; 15:235-239
16. Bonello RS, Fletcher CE, Becker WK, et al: An intensive care unit quality improvement collaborative in nine department of Veterans Affairs hospitals: Reducing ventilator associated pneumonia and catheter-related bloodstream infection rates. Jt Comm J Qual Patient Saf 2008; 34:639-645
17. Costello JM, Morrow DF, Graham DA, et al: Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008; 121:915-923
18. Galpern D, Guerrero A, Tu A, et al: Effectiveness of a central line bundle campaign on line-associated infections in the intensive care unit. Surgery 2008; 144:492-495
19. Venkatram S, Rachmale S, Kanna B: Study of device use adjusted rates in health care-associated infections after implementation of "bundles" in a closed-model medical intensive care unit. J Crit Care 2010; 25:174.e11-e18
20. Boyce JM, Pittet D: Guideline for hand hygiene in health-care settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 2002; 23:S3-S41
21. Forsyth Medical Center News Releases, November 12, 2008. Available at http://www.forsythmedicalcenter.org. Accessed June 7, 2010
22. Yilmaz G, Koksal I, Aydin K, et al: Risk factors of catheter-related bloodstream infections in parenteral nutrition catheteriza-tion. JPEN J Parenter Enteral Nutr 2007; 31:284-287 (Pubitemid 47025690)
23. Rosenthal VD, Guzman S, Safdar N: Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 2005; 33:392-397
24. Mermel LA, McCormick RD, Springman SR, et al: The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular subtyping. Am J Med 1991; 91:S197-S205
25. Raad II, Hohn DC, Gilbreath J, et al: Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15:231-238
26. Ayliffe GA: Surgical scrub and skin disinfection. Infect Control 1984; 5:23-27
27. Lowbury EJ, Lilly HA: The effect of blood on disinfection of surgeons' hands. Br J Surg 1974; 61:19-21
28. Chaiyakunapruk N, Veenstra DL, Lipsky BA, et al: Chlorhexidine compared with povi-done-iodine solution for vascular cathetersite care: A meta-analysis. Ann Intern Med 2002; 136:792-801
29. Maki DG, Ringer M, Alvarado CJ: Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339-343
30. Garland JS, Buck RK, Maloney P, et al: Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: A prospective trial. Pediatr Infect Dis J 1995; 14:510-516
31. Mimoz O, Villeminey S, Ragot S, et al: Chlo-rhexidine-based antiseptic solution vs. alcohol-based povidone-iodine for central venous catheter care. Arch Intern Med 2007; 167:2066-2072
32. Valles J, Fernandez I, Alcaraz D, et al: Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients. Infect Control Hosp Epidemiol 2008; 29:847-853
33. Rjinders BJ, Van Wigngaerden E, Peeter-mans WE: Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence? Clin Infect Dis 2002; 35:1053-1058
34. Humar A, Ostromecki A, Direnfeld J, et al: Prospective randomized trial of 10% povi-done-iodine versus 0.5% tincture of chlo-rhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000; 31: 1001-1007
35. Richards RM, McBride RJ: Enhancement of benzalkonium chloride and chlorhexidine acetate activity against Pseudomonas aeruginosa by aromatic alcohol. J Pharm Sci 1973; 52:2035-2037
36. Bozzetti F, Terno G, Bonfanti G, et al: Pathogenesis and predictability of central venous catheter sepsis. Surgery 1982; 91: 383-389
37. Merrer J, De Jonghe B, Golliot F, et al: Complications of femoral and subclavian venous catheterization in critically ill patients: A randomized controlled trial. JAMA 2001; 286:700-707
38. Goetz AM, Wagener MM, Miller JM, et al: Risk of infection due to central venous catheters: Effect of site placement and catheter type. Infect Control Hosp Epidemiol 1998; 19:842-845
39. Lorente L, Henry C, Martin MM, et al: Central venous catheter-related infection in a prospective and observational study of 2595 catheters. Crit Care 2005; R631-R635
40. Deshpande KS, Hatem C, Ulrich HL, et al: The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in the intensive care unit population. Crit Care Med 2005; 33:13-20
41. Parienti JJ, Thirion M, Megurbane B, et al: Femoral vs. jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: A randomized controlled trial. JAMA 2008; 299:2413-2422
42. Maki DG, Stoltz SM, Wheeler S, et al: Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: A randomized, controlled trial. Ann Intern Med 1997; 127: 257-266
43. Raad I, Darouiche R, Dupuis J, et al: Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: A randomized, double-blind trial. Ann Intern Med 1997; 127:267-274
44. Darouche RO, Raad II, Heard SO, et al: A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999; 340:1-8
45. Rupp ME, Lisco SJ, Lipsett PA, et al: Effect of a second generation venous catheter impregnated with chlorhexidine and sliver sul-fadiazine on central catheter-related infections: A randomized, controlled trial. Ann Intern Med 2005; 143:570-580
46. Bassetti S, Hu J, D'Agostino RB Jr, et al: Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadi-azine extends protection against catheter infections in vivo. Antimicrob Agents Che-mother 2001; 45:1535-1538
47. Casey AL, Mermel LA, Nightingale P, et al: Antimicrobial central venous catheters in adults: A systematic review and meta-analysis. Lancet Infect Dis 2008; 8:763-776
48. Marik PE, Abraham G, Careau P, et al: The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 1999; 27:1128-1131
49. Raad I, Darouiche R, Hachem R, et al: The broad-spectrum activity and efficacy of catheters coated with minocycline and ri-fampin. J Infect Dis 1996; 173:418-424
50. Leon C, Ruiz-Santana S, Rello J, et al: Benefits of minocycline and rifampin-impreg-nated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Med 2004; 30:1891-1899
51. Sampath LA, Tambe SM, Modak SM: In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: Evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 2001; 22: 640-646
52. Hanna H, Benjamin R, Chatzinikolaou I, et al: Long-term silicone central venous catheters impregnated with minocycline and ri-fampin decrease rates of catheter-related bloodstream infection in cancer patients: A prospective randomized clinical trial. J Clin Oncol 2004; 22:3163-3171
53. Hanna H, Raad II, Hackett B, et al: Antibiotic-impregnated catheters associated with significant decrease in nosocomial and mul-tidrug-resistant bacteremias in critically ill patients. Chest 2003; 124:1030-1038
54. Chatzinikolaou I, Hanna H, Graviss L, et al: Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance. Infect Control Hosp Epidemiol 2003; 24:961-965
55. Wright F, Heyland DK, Drover JW, et al: Antibiotic-coated central lines: do they work in the critical care setting? Clin Intensive Care 2001; 12:21-28
56. Maki DG, Ringer M: Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters: gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA 1987; 258:2396-2403
57. Maki DG, Stolz SS, Wheeler S, et al: A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: Implications for catheter management. Crit Care Med 1994; 22:1729-1737
58. Dickerson N, Horton P, Smith S, et al: Clinically significant central venous catheter infections in a community hospital: Association with type of dressing. J Infect Dis 1989; 160:720-721
59. Conly JM, Grieves K, Peters B: A prospective, randomized study comparing transparent and dry gauze dressing for central venous catheters. J Infect Dis 1989; 159: 310-319
60. Hoffman KK, Weber DJ, Samsa GP, et al: Transparent polyurethane film as an intravenous catheter dressing: A meta-analysis of the infection risks. JAMA 1992; 267: 2072-2076
61. Maki DG, Mermel LA, Kluger D, et al: The Efficacy of a Chlorhexidine-Impregnated Sponge (Biopatch) for the Prevention of In-travascular Catheter-Related Infection\A Prospective, Randomized, Controlled, Mul-ticenter Study. Abstract. In: Abstracts and Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 17-20, 2000, Toronto, ON, Canada
62. Garland JS, Alex CP, Mueller CD, et al: A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-im-pregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001; 107:1431-1436
63. Levy I, Katz J, Solter E, et al: Chlorhexi-dine-impregnated dressing for prevention of colonization of central venous catheters in infants and children. Pediatr Infect Dis J 2005; 24:676-679
64. Ho KM, Litton E: Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: A meta-analysis. J Antimicrob Che-mother 2006; 58:281-287
65. Timsit JF, Schwebel C, Bouadma L, et al: Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults. JAMA 2009; 301:1231-1241
66. Rasero L, Degl'Innocenti M, Mocali M, et al: Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. Haematologica 2000; 85:275-279
67. Safdar N, Maki DG: Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: A meta-analysis of prospective, randomized trials. Clin Infect Dis 2006; 43:474-484
68. Carratala J, Niubo J, Fernandez-Sevilla A, et al: Randomized, double-blind trial of an antibiotic-lock technique for prevention of Gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 1999; 43:2200-2204
69. Garland JS, Alex CP, Henrickson KJ, et al: A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: A prospective, randomized trial. Pediatrics 2005; 116:e198-e205
70. Maiefski M, Rupp ME, Hermsen ED: Etha-nol lock technique: review of the literature. Infect Control Hosp Epidemiol 2009; 30: 1096-1108
71. Bleyer AJ: Use of antimicrobial lock solutions to prevent catheter-related bactere-mia. Clin J Am Soc Nephrol 2007; 2:1073-1078
72. McKee R, Dunsmuir R, Whitby M, et al: Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J Hosp Infect 1985; 6:419-425
73. Ranson MR, Oppenheim BA, Jackson A, et al: Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990; 15:95-102
74. Ljungman P, Hagglund H, Bjorkstrand B, et al: Perioperative teicoplanin for prevention of Gram-positive infections in neutropenic patients with indwelling central venous catheters: A randomized, controlled study. Support Care Cancer 1997; 5:485-488
75. Van de Wetering MD, van Woensel JBM, Kremer LCM, et al: Prophylactic antibiotics for preventing early Gram-positive central venous catheter infections in oncology patients, a Cochrane systematic review. Cancer Treat Rev 2005; 31:186-196
76. Herrmann M, Vaudaux PE, Pittet D, et al: Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphy-loccal isolates to foreign material. J Infect Dis 1988; 158:693-701
77. Vaudaux P, Pittet D, Haeberli A, et al: Host factors selectively increase staphylococcal adherence on inserted catheters: A role for fibronectin and fibrinogen or fibrin. J Infect Dis 1989; 160:965-975
78. Mehall JR, Saltzman DA, Jackson RJ, et al: Fibrin sheath enhances central venous catheter infection. Crit Care Med 2002; 30: 908-912
79. Raad II, Luna M, Khalil SAM, et al: The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994; 271:1014-1016
80. Timsit JF, Farkas JC, Boyer JM, et al: Central vein catheter-related thrombosis in intensive care patients: Incidence, risk factors, and relationship with catheter-related sepsis. Chest 1998; 114:207-213
81. Randolph AG, Cook DJ, Gonzaolez CA, et al: Benefit of heparin in central venous and pulmonary artery catheters: A meta-analy-sis of randomized controlled trials. Chest 1998; 113:165-171
82. Bern MM, Lokich JJ, Wallach SR, et al: Very low doses of warfarin can prevent thrombosis in central venous catheters: A randomized prospective trial. Ann Intern Med 1990; 112:423-428
83. Boraks P, Seale J, Price J, et al: Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haem 1998; 101:483-486
84. Abdelkefi A, Torjman L, Ladeb S, et al: Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease. J Clin Oncol 2005; 23: 7864-7870
85. Pierce CM, Wade A, Mok Q: Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med 2000; 26:967-972
86. Krafte-Jacobs B, Sivit CJ, Mejia R, et al: Catheter-related thrombosis in critically ill children: Comparison of catheters with and without heparin bonding. J Pediatr 1995; 126:50-54
87. Mermel LA, Stolz SM, Maki DG: Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. J Infect Dis 1993; 167:920-924
88. Kethireddy S, Safdar N: Urokinase lock or flush solution for prevention of bloodstream infections associated with central venous catheters for chemotherapy: A meta-analysis of prospective randomized trials. J Vasc Access 2008; 9:51-57
89. Van Rooden CJ, Schippers EF, Guiot HFL, et al: Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: A randomized double-blind controlled trial in patients with hematologic malignancies. J Clin Oncol 2008; 26:428-433
90. Eyer S, Brummitt C, Crossley K, et al: Catheter-related sepsis: Prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med 1990; 18: 1073-1079
91. Cobb DK, High KP, Sawyer RG, et al: A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 1992; 327:1062-1068
92. Cook D, Rudolph A, Kernerman P, et al: Central venous catheter replacement strategies: A systematic review of the literature. Crit Care Med 1997; 25:1417-1424
93. Lederle FA, Parenti CM, Berskow LC, et al: The idle intravenous catheter. Ann Intern Med 1992; 116:737-738
94. Field K, McFarlane C, Cheng AC, et al: Incidence of catheter-related bloodstream infection among patients with a needleless, mechanical valve-based intravenous connector in an Australian hematology-oncol-ogy unit. Infect Control Hosp Epidemiol 2007; 28:610-613
95. Salgado CD, Chinnes L, Paczesny TH, et al: Increased rate of catheter-related bloodstream infection associated with the use of a needleless mechanical valve device at a long-term acute care hospital. Infect Control Hosp Epidemiol 2007; 28:684-688
96. Rupp ME, Sholtz LA, Jourdan DR, et al: Outbreak of bloodstream infection temporally associated with the use of an intravas-cular needleless valve. Clin Infect Dis 2007; 44:1408-1414
97. Margakis LL, Bradley KL, Song X, et al: Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 2006; 27: 67-70
98. Danzig LE, Short LJ, Collins K, et al: Bloodstream infections associated with a needle-less intravenous infusions system in patients receiving home infusion therapy. JAMA 1995; 273:1862-1864
99. Kellerman S, Shay DK, Howard J, et al: Bloodstream infections in home infusion patients: The influence of race and needle-less intravascular access devices. J Pediatr 1996; 129:711-717
100. Cookson ST, Ihrig M, O'Mara EM, et al: Increased bloodstream infection rates in surgical patients associated with variation from recommended use and care following implementation of a needleless device. Infect Control Hosp Epidemiol 1998; 19: 23-27
101. Jarvis WR, Murphy C, Hall KK, et al: Health care-associated bloodstream infections associated with negative-or positive-pressure or displacement mechanical valve needle-less connectors. Clin Infect Dis 2009; 49: 1821-1827
102. Salzman MB, Isenberg HD, Rubin LG: Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol 1993; 31:475-479
103. Luebke MA, Arduino MJ, Duda DL, et al: Comparison of the microbial barrier properties of a needleless and a conventional needle-based intravenous access system. Am J Infect Control 1998; 26:437-441
104. Casey AL, Worthington T, Lambert PA, et al: A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector. J Hosp Infect 2003; 54:288-293
105. Gillies D, O'Riordan L, Wallen M, et al: Optimal timing for intravenous administration set replacement. Cochrane Database Syst Rev 2005; 4:1-42
106. Bleasdale SC, Trick WE, Gonzalez IM, et al: Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007; 167: 2073-2079
107. Climo MW, Sepkowitz KA, Zuccotti G, et al: The effect of daily bathing with chlorhexi-dine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomy-cin-resistant enterococcus, and healthcare-associated bloodstream infections: Results of a quasi-experimental multicenter trial. Crit Care Med 2009; 37:1858-1865
108. Gastmeier P, Geffers C, Brandt C, et al: Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect 2006; 64:16-22
109. Mermel LA, Allon M, Bouza E, et al: Clinical practice guidelines for the diagnosis of in-travascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1-45
110. Safdar N, Maki DG: Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med 2002; 30:2632-2635
111. Armstrong CW, Mayhall GC, Miller KB, et al: Clinical predictors of infection of central venous catheters used for total parenteral nutrition. Infect Control Hosp Epidemiol 1990; 11:71-78
112. Pittet D, Chouard C, Rae AC, et al: Clinical diagnosis of central venous catheter line infection: A difficult job. Abstract. In: Abstracts and Proceedings of the 31st Inter-science Conference on Antimicrobial Agents and Chemotherapy, September 29-October 2 1991, Chicago, IL
113. Shukrallah B, Hanna H, Hachem R, et al: Correlation between early clinical response after catheter removal and diagnosis of catheter-related bloodstream infection. Di-agn Microbiol Infect Dis 2007; 58:453-457
114. Little JR, Murray PR, Traynor PS, et al: A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: Effects on rates of blood culture contamination. Am J Med 1999; 107:119-125
115. Mimoz O, Karim A, Mercat A, et al: Chlo-rhexidine compared with povidone-iodine as skin preparation before blood culture: A randomized, controlled trial. Ann Intern Med 1999; 131:834-837
116. Bekeris LG, Tworek JA, Walsh MK, et al: Trends in blood culture contamination: A College of American Pathologists Q-Tracks study of 356 institutions. Arch Pathol Lab Med 2005; 129:1222-1225
117. Everts RJ, Vinson EN, Adholla PO, et al: Contamination of catheter-drawn blood cultures. J Clin Microbiol 2001; 39: 3393-3394
118. Ramsook C, Childers K, Cron SG, et al: Comparison of blood-culture contamination rates in a pediatric emergency room: Newly inserted intravenous catheters versus venipuncture. Infect Control Hosp Epidemiol 2000; 21:649-651
119. DesJardin JA, Falagas ME, Ruthazer R, et al: Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med 1999; 131:641-647
120. Martinez JA, DesJardin JA, Aronoff M, et al: Clinical utility of blood cultures drawn from central venous or arterial catheters in critically ill surgical patients. Crit Care Med 2002; 30:7-13
121. Raad II, Hanna HA, Darouiche RO, et al: Diagnosis of catheter-related bloodstream infections: Is it necessary to culture the subcutaneous catheter segment? Eur J Clin Microbiol Infect Dis 2001; 20:566-568
122. Kristinsson KG, Burnett IA, Spencer RC: Evaluation of three methods for culturing long intravascular catheters. J Hosp Infect 1989; 14:183-191
123. Raad II, Sabbagh MF, Rand KH, et al: Quantitative tip culture methods and the diagnosis of central venous catheter-related infections. Diagn Microbiol Infect Dis 1992; 15: 13-20
124. Sherertz RJ, Heard SO, Raad II: Diagnosis of triple lumen catheter infection: Comparison of roll plate, sonication, and flushing methodologies. J Clin Microbiol 1997; 35: 641-646
125. Maki DG, Mermel L, Martin M, et al: A prospective comparison of semiquantitative and sonication cultures of catheter segments for diagnosis of CVC-related BSI. Abstract. In: Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC, American Society for Microbiology, 1996
126. Widmer AF: Diagnosis of central venous catheter-related infection: comparison of the roll-plate and sonication technique in 1000 catheters. Abstract. In: Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC, American Society for Microbiology, 2003
127. Bouza E, Alvarado N, Alcala L, et al: A prospective, randomized, and comparative study of 3 different methods for the diagnosis of intravascular catheter colonization. Clin Infect Dis 2005; 1096-1100
128. Safdar N, Fine JP, Maki DG: Meta-analysis: Methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med 2005; 142:451-466
129. Blot F, Schmidt S, Nittenberg G, et al: Earlier positivity of central-venous versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998; 36:105-109
130. Blot F, Nittenberg G, Chachaty E, et al: Diagnosis of catheter-related bacteremia: A prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999; 354:1071-1077
131. Raad I, Hanna HA, Alakech B, et al: Differential time to positivity: A useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 2004; 140: 18-25
132. Rijnders BJ, Verwaest C, Peetermans WE, et al: Difference in time to positivity of hub-blood versus nonhub-blood cultures is not useful for the diagnosis of catheter-related bloodstream infection in critically ill patients. Crit Care Med 2001; 29: 1399-1403